Published: 2016-12-27

Study of prevalence of non alcoholic fatty liver disease in type 2 diabetes mellitus patients and variations in liver function tests, lipid profile and mean platelet volume in patients with fatty liver in comparison with patients without fatty liver

Nagaraj S., Sunitha S. Kiran, Rajeev Gandham, Wilma Delphine Silvia C. R., Nagaraja M. R., Abdul Nasar S., Biswajit Das


Background: Type 2 diabetes mellitus (T2DM) patients potentially are at risk of developing non-alcoholic fatty liver disease. The aim of the study is to determine the prevalence of NAFLD among T2DM patients, diagnosed by ultrasonography of liver, to study the age & sex incidence of NAFLD and to compare the liver function tests, lipid profile and mean platelet volume (MPV) between individuals with NAFLD and without NAFLD.

Methods: Total of 97 type 2 diabetes mellitus ambulatory patients were selected for the study. Among them 62 were males (63.9%) and 35 were females (36%). 78 healthy subjects were selected as controls. Their age ranged between 27 to 75 years. Serum was used for the estimation of FBS, PPBS, total bilirubin, direct bilirubin, AST, ALT, ALP, GGT, total protein, albumin, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). EDTA blood was used for the estimation of MPV. Fatty liver was diagnosed on ultrasound based on the echogenicity and size of the liver.

Results: In this study, liver size & echotexture, liver enzymes such as AST, ALT, ALP and GGT, serum cholesterol, TGL and LDLC were found to be statistically significantly increased in T2DM patients when compared to controls. T2DM patients were divided in to two groups; group 1 included patients with NAFLD and group 2 included patients without NAFLD. Liver size, AST, ALT, ALP, GGT, Cholesterol and TGL were significantly increased in group 1 patients when compared to group 2 patients (P value<0.05). Elevation of MPV was found to be more in group 1 patients than group 2 patients ranging between 12.1±3.0 and 10.2±0.9 respectively.

Conclusions: Early detection and optimum control of diabetes mellitus is important to minimize the effect of diabetes on liver. Hence, assay of serum levels of hepatic enzymes and USG abdomen to detect NAFLD should be done in all patients with T2DM as preliminary diagnostic tests.



ALP, ALT, AST, GGT, Non alcoholic fatty liver disease

Full Text:



Agarawal J. Prevalence of elevated hepatic enzymes among north Indian patients with type 2 diabetes mellitus. Santosh University Journal of Health Sciences. 2015;1(1):3-6.

King GL. The role of inflammatory cytokines in the diabetes and its complications. J Periodontal. 2008;(1):1527-34.

Kumar KPS. Bhowmik D, Srivastava S, Paswan S, Dutta AS. Diabetes epidemic in India-A comprehensive review of clinical features, management and remedies. The pharma innovation. 2012;2:17-33.

Prabhudeva N, Ghouse P Mounika K. Hepatic Dysfunction in Diabetes Mellitus: Biochemical and Ultrasonological Study. Journal of Academia and Industrial Research. 2014;3(4):164-7.

Elmahi HM, Abdrabo AA. Determinants of abnormal liver function tests in Diabetes Type 2 patients in Sudan. Journal of Science. 2014;4(1):45-9.

Luxmi S, Sattar RA Ara J. Association of Non Alcoholic fatty Liver with Type 2 Diabetes Mellitus. JLUMHS. 2008:188-93.

Perez BG, Flores RS, Guzmán AE, Chavez SP, Mata AG. Elevated liver enzymes impaired fasting glucose and undiagnosed diabetes. Rev Med Inst Mex Seguro Soc. 2011;49(3):247-52.

Merat S, Yarahmadi S, Tahaghoghi S, Alizadeh Z, Sedighi N, Mansournia N, et al. Prevalence of fatty Liver Disease among Type 2 Diabetes Mellitus Patients and its Relation to Insulin Resistance. Middle East Journal of Digestive Diseases. 2009;1(2):74-9.

Rajeswari S, Kumar A, Gandhi M, Swaminathan S. Association between Lipid Profile and Liver Function Tests in Diabetic Patients. International Journal of Pure Science & Applied Bioscience. 2014;2(4):26-31.

Atiba AS, Oparinde DP, Babatunde OA, Niran-Atiba TA, Jimoh AK, Adepeju AA. Liver Enzymes and Lipid Profile Among Type 2 Diabetic Patients in Osogbo, Nigeria. Greener Journal of Medical Sciences. 2013;3(5):174-8.

Yenigün EC, Okyay GU, Pirpir A, Hondur A, Yıldırım IS. Increased mean platelet volume in type 2 diabetes mellitus. Dicle Medical Journal. 2014;41(1):17-22.

Hamer Ow, Aguirre DA, Casola G, Lavine JE, Woenkhaus M, Sirlin CB. Fatty liver: Imaging patterns and pitfalls. Radio Graphics. 2006;26(6):1637-53.

Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HKM. Mean Platelet Volume in Type 2 Diabetes Mellitus. Journal of Laboratory Physicians. 2012;4(1):5-9.

Saadeh S. Nonalcoholic Fatty Liver Disease and Obesity. Nutrition in Clinical Practice. 2007;22(1):1-10.

Han Ni, Soe HHK, Htet A. Determinants of Abnormal Liver Function Tests in Diabetes Patients in Myanmar. International Journal of Diabetes Research. 2012;1(3):36-41.

Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE. Gammaglutamyl transferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49:1358-66.

IM Paruk, FJ Pirie, AA Motala, BA Kolawole. High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetic clinic. Journal of Endocrinology, Metabolism and Diabetes of South Africa. 2011;16(1):42-5.

Patra TK, Paul R, Mandal SK. Liver function tests in type 2 diabetes mellitus patients with and without oral hypoglycaemic agents and statin intake. Indian Medical Gazette. 2012:388-93.

Idris AS, Mekky KFH, Abdalla BEE, Ali KA. Liver function tests in type 2 Sudanese diabetic patients. International Journal of Nutrition and Metabolism. 2011;3(2):17-21.

Cakir L, Gulaliaktas, Enginyurt O, Cakir S. Mean Platelet Volume Increases In Type 2 Diabetes Mellitus Independent Of Hba1c Level. Acta Medica Mediterranea. 2014;30:425-8.